Business Description
Pharmala Biotech Holdings Inc
NAICS : 541714
SIC : 3741
ISIN : CA71719L1067
Description
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.73 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 10.68 | |||||
| Beneish M-Score | -2.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 41.5 | |||||
| 3-Year EPS without NRI Growth Rate | 30.7 | |||||
| 3-Year FCF Growth Rate | -6.3 | |||||
| 3-Year Book Growth Rate | -13.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.86 | |||||
| 9-Day RSI | 17.44 | |||||
| 14-Day RSI | 26.17 | |||||
| 3-1 Month Momentum % | -21.74 | |||||
| 6-1 Month Momentum % | 140.71 | |||||
| 12-1 Month Momentum % | 15.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 0.59 | |||||
| Cash Ratio | 0.27 | |||||
| Days Sales Outstanding | 389.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -453.06 | |||||
| Net Margin % | -477.55 | |||||
| FCF Margin % | -299.07 | |||||
| ROE % | -41.68 | |||||
| ROA % | -27.02 | |||||
| ROIC % | -30.51 | |||||
| 3-Year ROIIC % | 95.2 | |||||
| ROC (Joel Greenblatt) % | -39960 | |||||
| ROCE % | -39.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 90 | |||||
| PB Ratio | 9 | |||||
| EV-to-EBIT | -25.19 | |||||
| EV-to-EBITDA | -27.01 | |||||
| EV-to-Revenue | 114.11 | |||||
| EV-to-FCF | -37.61 | |||||
| Earnings Yield (Greenblatt) % | -3.97 | |||||
| FCF Yield % | -2.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MDXXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmala Biotech Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.108 | ||
| EPS (TTM) ($) | -0.002 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 191.38 | ||
| 14-Day RSI | 26.17 | ||
| 14-Day ATR ($) | 0.009009 | ||
| 20-Day SMA ($) | 0.168117 | ||
| 12-1 Month Momentum % | 15.62 | ||
| 52-Week Range ($) | 0.04005 - 0.2563 | ||
| Shares Outstanding (Mil) | 94.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmala Biotech Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmala Biotech Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmala Biotech Holdings Inc Frequently Asked Questions
What is Pharmala Biotech Holdings Inc(MDXXF)'s stock price today?
The current price of MDXXF is $0.12. The 52 week high of MDXXF is $0.26 and 52 week low is $0.04.
When is next earnings date of Pharmala Biotech Holdings Inc(MDXXF)?
The next earnings date of Pharmala Biotech Holdings Inc(MDXXF) is .
Does Pharmala Biotech Holdings Inc(MDXXF) pay dividends? If so, how much?
Pharmala Biotech Holdings Inc(MDXXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers